Levetiracetam Tablet
Product Images NDC 71335-2282

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 71335-2282). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Str (Ectdmodule1usa1)

FDA Label Image

Fig 1 (Ectdmodule1usa2)

FDA Label Image

Fig 2 (Ectdmodule1usa3)

This text appears to represent the percentage of patients in a study who received different treatments. The first column shows the percentage of patients, with values of 35.2%, 20.8%, and 6.3%. The second and third columns indicate the treatments received, including a placebo group (N=111) and two groups treated with different dosages of Levetiracetam (N=106 for 1000 mg/day and N=105 for 2000 mg/day).*

FDA Label Image

Fig 3 (Ectdmodule1usa4)

FDA Label Image

Fig 4 (Ectdmodule1usa5)

This text provides a comparison of percentages in relation to patients. It includes numbers ranging from 45% to 20% and mentions two groups named "Placebo" and "Levetiracetam" along with the respective sample sizes of each group.*

FDA Label Image

5 (Ectdmodule1usa6)

FDA Label Image

Fig 6 (Ectdmodule1usa7)

FDA Label Image

Logo (Ectdmodule1usa8)

FDA Label Image

Image (Ectdmodule1usa9)

FDA Label Image

Label (Lbl713352282)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.